{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:56:01Z","timestamp":1771001761648,"version":"3.50.1"},"reference-count":188,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Centre, Poland","award":["2021\/43\/D\/NZ5\/02471"],"award-info":[{"award-number":["2021\/43\/D\/NZ5\/02471"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Thyroid cancer (TC), due to its heterogeneous nature, remains a clinical challenge. Many factors can initiate the carcinogenesis process of various types of TC, which complicates diagnosis and treatment. The presented review gathers current information on specific types of TC, taking into account the effects of the COVID-19 pandemic. It is likely that COVID-19 has influenced and continues to influence the function of the thyroid gland. A high percentage of patients with COVID-19 showing simultaneous pathological changes in the thyroid suggests that SARS-CoV-2 may disrupt the function of this gland and initiate pro-oxidative mechanisms, inflammatory states, and autoimmune diseases, thereby promoting the formation of neoplastic changes. Furthermore, changes in the expression of the ACE2, TMPRSS2, CLEC4M and DPP4 genes, observed in TC, also occur in COVID-19. Therefore, it is probable that the interaction of SARS-CoV-2 with thyroid cell receptors may initiate carcinogenesis in this gland. Additionally, some drugs used in TC therapy (e.g., levothyroxine) may increase the affinity of SARS-CoV-2 for cells, which could contribute to a more severe course of COVID-19 and the emergence of long-term symptoms (post-COVID-19). Moreover, the consequences of sanitary restrictions (limited access to medical services, reduction in endocrinological and oncological procedures) that took place in many countries during the COVID-19 pandemic may lead in the future to an increased number of missed diagnoses and the emergence of aggressive cancers.<\/jats:p>","DOI":"10.3390\/biomedicines12122829","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T03:51:08Z","timestamp":1734061868000},"page":"2829","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["State of Knowledge About Thyroid Cancers in the Era of COVID-19\u2014A Narrative Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-036X","authenticated-orcid":false,"given":"Agnieszka","family":"Bronowicka-Szyde\u0142ko","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Rabczy\u0144ski","sequence":"additional","affiliation":[{"name":"Clinical Department of Diabetology, Hypertension and Internal Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-3628","authenticated-orcid":false,"given":"Ilias","family":"Dumas","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiotherapy and Rehabilitation, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017banna","family":"Fiodorenko-Dumas","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiotherapy and Rehabilitation, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Wojtczak","sequence":"additional","affiliation":[{"name":"University Center for General and Oncological Surgery, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Kotyra","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Kustrzeba-W\u00f3jcicka","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-631X","authenticated-orcid":false,"given":"\u0141ukasz","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Ponikowska","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Division of Physiology, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-8174","authenticated-orcid":false,"given":"Aleksandra","family":"Kuzan","sequence":"additional","affiliation":[{"name":"Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Wroclaw University of Science and Technology, 51-377 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kluz","sequence":"additional","affiliation":[{"name":"Clinical Department of Diabetology, Hypertension and Internal Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-6591","authenticated-orcid":false,"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[{"name":"Hirszfeld Institute of Immunology and Experimantal Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-3691","authenticated-orcid":false,"given":"Katarzyna","family":"Madziarska","sequence":"additional","affiliation":[{"name":"Clinical Department of Diabetology, Hypertension and Internal Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/pin.12737","article-title":"The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives","volume":"68","author":"Kakudo","year":"2018","journal-title":"Pathol. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.path.2019.08.002","article-title":"Molecular Alterations in Thyroid Carcinoma","volume":"12","author":"Xu","year":"2019","journal-title":"Surg. Pathol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bronowicka-Szyde\u0142ko, A., Kotyra, \u0141., Lewandowski, \u0141., Gamian, A., and Kustrzeba-W\u00f3jcicka, I. (2021). Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184084"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1507\/endocrj.EJ17-0026","article-title":"Natural history of thyroid cancer [Review]","volume":"64","author":"Takano","year":"2017","journal-title":"Endocr. J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hlozek, J., Pekova, B., Rotn\u00e1gl, J., Hol\u00fd, R., and Astl, J. (2022). Genetic Changes in Thyroid Cancers and the Importance of Their Preoperative Detection in Relation to the General Treatment and Determination of the Extent of Surgical Intervention\u2014A Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071515"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.mayocp.2020.06.018","article-title":"Targeting TMPRSS2 in SARS-CoV-2 Infection","volume":"95","author":"Baughn","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gudima, G., Kofiadi, I., Shilovskiy, I., Kudlay, D., and Khaitov, M. (2023). Antiviral Therapy of COVID-19. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108867"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/thy.2018.0509","article-title":"Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects","volume":"29","author":"Ibrahimpasic","year":"2019","journal-title":"Thyroid"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tsou, P., and Wu, C.-J. (2019). Mapping Driver Mutations to Histopathological Subtypes in Papillary Thyroid Carcinoma: Applying a Deep Convolutional Neural Network. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101675"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s00268-020-05487-1","article-title":"Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules","volume":"44","author":"Ravella","year":"2020","journal-title":"World J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.14486","article-title":"The Clinical Outcomes of COVID-19 Infection in Patients with a History of Thyroid Cancer: A Nationwide Study","volume":"95","author":"Sahin","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hinnebusch, A.G., and Lorsch, J.R. (2012). The mechanism of eukaryotic translation initiation: New insights and challenges. Cold Spring Harb. Perspect. Biol., 4.","DOI":"10.1101\/cshperspect.a011544"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-18-0606","article-title":"EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis Through ATF4 and C-MYC","volume":"9","author":"Krishnamoorthy","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11912-021-01019-9","article-title":"Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics","volume":"23","author":"Abe","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41467-019-10680-5","article-title":"Integrative Analysis of Genomic and Transcriptomic Characteristics Associated with Progression of Aggressive Thyroid Cancer","volume":"10","author":"Yoo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e12903","DOI":"10.1111\/cpr.12903","article-title":"Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells","volume":"53","author":"Li","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1158\/0008-5472.CAN-04-4259","article-title":"Mutation of the PIK3CA Gene in Anaplastic Thyroid Cancer","volume":"65","author":"Costa","year":"2005","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/TACG.S41947","article-title":"Genetic Basis of Cowden Syndrome and Its Implications for Clinical Practice and Risk Management","volume":"9","author":"Gammon","year":"2016","journal-title":"Appl. Clin. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e210112","DOI":"10.1001\/jamanetworkopen.2021.0112","article-title":"A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype","volume":"4","author":"Mirshahi","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI84894","article-title":"Recurrent EZH1 Mutations Are a Second Hit in Autonomous Thyroid Adenomas","volume":"126","author":"Calebiro","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2018.08.027","article-title":"Cancer Mutations of the Tumor Suppressor SPOP Disrupt the formation of Active, Phase-Separated Compartments","volume":"72","author":"Bouchard","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.7150\/jca.25930","article-title":"Functional Roles of Speckle-Type Poz (SPOP) Protein in Genomic Stability","volume":"9","author":"Wei","year":"2018","journal-title":"J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Miasaki, F.Y., Fuziwara, C.S., de Carvalho, G.A., and Kimura, E.T. (2020). Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer. Genes, 11.","DOI":"10.3390\/genes11111364"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated Analysis of TP53 Gene and Pathway Alterations in the Cancer Genome Atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ecl.2018.10.003","article-title":"Coding Molecular Determinants of Thyroid Cancer Development and Progression","volume":"48","author":"Valvo","year":"2019","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Dratwa, M., Wysocza\u0144ska, B., \u0141acina, P., Kubik, T., and Bogunia-Kubik, K. (2020). TERT\u2014Regulation and Roles in Cancer formation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.589929"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Santoro, M., Moccia, M., Federico, G., and Carlomagno, F. (2020). RET Gene Fusions in Malignancies of the Thyroid and Other Tissues. Genes, 11.","DOI":"10.3390\/genes11040424"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/PAS.0000000000001301","article-title":"NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is \u201cIntraductal\u201d Correct?","volume":"43","author":"Santana","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2014.115","article-title":"PAX8-PPAR\u03b3 Fusion Protein in Thyroid Carcinoma","volume":"10","author":"Raman","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS Point Mutations and PAX8-PPAR\u03b3 Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.240336397","article-title":"Pax8 Has a Key Role in Thyroid Cell Differentiation","volume":"97","author":"Zannini","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","article-title":"Cribriform-Morular Variant of Thyroid Carcinoma: A Neoplasm with Distinctive Phenotype Associated with the Activation of the WNT\/\u0392-Catenin Pathway","volume":"31","author":"Abdulkader","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1530\/ERC-17-0513","article-title":"Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Impact on the Reclassification of Thyroid Nodules","volume":"25","author":"Amendoeira","year":"2018","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000369676","article-title":"MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3","volume":"35","author":"Deng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0000000000000248","article-title":"Follicular Cell Thyroid Neoplasia: Insights from Genomics and the Cancer Genome Atlas Research Network","volume":"28","author":"Giordano","year":"2016","journal-title":"Curr. Opin. Oncol."},{"key":"ref_38","first-page":"915925","article-title":"Papillary Thyroid Carcinoma: Differential Diagnosis and Prognostic Values of Its Different Variants: Review of the Literature","volume":"2011","year":"2011","journal-title":"ISRN Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jc.2006-1006","article-title":"Prevalence of RET\/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity","volume":"91","author":"Zhu","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/PAP.0000000000000184","article-title":"Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid","volume":"25","author":"Nath","year":"2018","journal-title":"Adv. Anat. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kaliszewski, K., Diakowska, D., Wojtczak, B., and Rudnicki, J. (2020). Cancer Screening Activity Results in Overdiagnosis and Overtreatment of Papillary Thyroid Cancer: A 10-Year Experience at a Single Institution. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236257"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1159\/000453190","article-title":"Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131 I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases","volume":"40","author":"Qiu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10689-014-9732-5","article-title":"Cribriform-Morular Variant of Papillary Thyroid Carcinoma: An Indication to Screen for Occult FAP","volume":"13","author":"Levy","year":"2014","journal-title":"Fam. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/dc.24312","article-title":"Pulmonary Metastasis of Cribriform-Morular Variant of Thyroid Carcinoma Mimicking Primary Adenocarcinoma of the Lung: A Potential Pitfall","volume":"48","author":"Laforga","year":"2020","journal-title":"Diagn. Cytopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bioe.12383","article-title":"Ethical issues raised by thyroid cancer overdiagnosis: A matter for public health?","volume":"31","author":"Rogers","year":"2017","journal-title":"Bioethics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/cncy.21441","article-title":"FNAB of benign thyroid nodules with papillary hyperplasia: A cytological and histological evaluation","volume":"122","author":"Pusztaszeri","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid Carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","article-title":"Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review","volume":"37","author":"Shah","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.2147\/CMAR.S304686","article-title":"The Correlation of Age with Prognosis of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodules","volume":"13","author":"Kaliszewski","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12020-023-03336-4","article-title":"The 5th Edition of WHO Classification of Tumors of Endocrine Organs: Changes in the Diagnosis of Follicular-Derived Thyroid Carcinoma","volume":"80","author":"Basolo","year":"2023","journal-title":"Endocrine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/000313480206801017","article-title":"Can Fine-Needle Aspiration Biopsy of Thyroid Nodule Help in Determining the Extent of Surgery in Follicular and Hurthle Cell Neoplasm at a Community Teaching Institution?","volume":"68","author":"Hawasli","year":"2002","journal-title":"Am. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e25070","DOI":"10.1097\/MD.0000000000025070","article-title":"Ultrasonographic Characteristics of Thyroid Nodule Rupture After Microwave Ablation","volume":"100","author":"Tian","year":"2021","journal-title":"Medicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MLG.0000200428.26975.86","article-title":"Aerodigestive Tract Invasion by Well-Differentiated Thyroid Carcinoma: Diagnosis, Management, Prognosis, and Biology","volume":"116","author":"McCaffrey","year":"2006","journal-title":"Laryngoscope"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"E914","DOI":"10.1210\/jc.2012-3396","article-title":"RAS Mutations in Thyroid FNA Specimens Are Highly Predictive of Predominantly Low-Risk Follicular-Pattern Cancers","volume":"98","author":"Gupta","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","first-page":"221","article-title":"Follicular Carcinoma of the Thyroid: An Evaluation of the Histologic Criteria Used for Diagnosis","volume":"18","author":"Kahn","year":"1983","journal-title":"Pathol. Annu."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.oraloncology.2013.03.440","article-title":"Anaplastic thyroid cancer","volume":"49","author":"Shaha","year":"2013","journal-title":"Oral Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6235417","DOI":"10.1155\/2018\/6235417","article-title":"Correlation of reactive oxygen species levels with resveratrol sensitivities of anaplastic thyroid cancer cells","volume":"2018","author":"Zheng","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_58","unstructured":"(2021, March 10). Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (Concept Id: C0238461)\u2014MedGen\u2014NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/medgen\/116064."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1158\/1535-7163.MCT-12-0841","article-title":"Resveratrol Induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth","volume":"12","author":"Yu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2008.02.004","article-title":"Intragenic Mutations in Thyroid Cancer","volume":"37","author":"Rocha","year":"2008","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-019-02708-4","article-title":"PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: A multi-institutional study of 182 cases using the monoclonal antibody MRQ-50","volume":"476","author":"Lai","year":"2020","journal-title":"Virchows Arch."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6180425","DOI":"10.1155\/2017\/6180425","article-title":"MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2","volume":"2017","author":"Yin","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11864-004-0022-6","article-title":"Multiple endocrine neoplasia type 2","volume":"5","author":"Gertner","year":"2004","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(00)00697-2","article-title":"Thyroid Cancer","volume":"163","author":"Gimm","year":"2001","journal-title":"Cancer Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1308\/003588406X117043","article-title":"Medullary Thyroid Carcinoma\u2014Update and Present Management Controversies","volume":"88","author":"Wheeler","year":"2006","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary Thyroid Carcinoma: Clinical Characteristics, Treatment, Prognostic Factors, and a Comparison of Staging Systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0030-6665(02)00136-6","article-title":"Medullary thyroid cancer","volume":"36","author":"Clayman","year":"2003","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ecl.2018.11.006","article-title":"Management of Medullary Thyroid Cancer","volume":"48","author":"Viola","year":"2019","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.hoc.2007.04.002","article-title":"Medullary Thyroid Carcinoma","volume":"21","author":"Hoff","year":"2007","journal-title":"Hematol.\/Oncol. Clin. N. Am."},{"key":"ref_70","first-page":"19-0094","article-title":"Concomitant Medullary Thyroid Carcinoma with Paraganglioma-Like Pattern and Papillary Thyroid Carcinoma","volume":"2019","author":"Greco","year":"2019","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0002-9440(10)65453-3","article-title":"Mixed Medullary and Follicular Carcinoma of the Thyroid: On the Search for Its Histogenesis","volume":"155","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.21873\/anticanres.12853","article-title":"Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management","volume":"38","author":"Owen","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cam4.287","article-title":"Primary Squamous Cell Carcinomas in the Thyroid Gland: An Individual Participant Data Meta-Analysis","volume":"3","author":"Cho","year":"2014","journal-title":"Cancer Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4132\/KoreanJPathol.2014.48.6.418","article-title":"Combined Squamous Cell Carcinoma and Follicular Carcinoma of the Thyroid","volume":"48","author":"Son","year":"2014","journal-title":"Korean J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.31486\/toj.18.0002","article-title":"Primary Squamous Cell Carcinoma of the Thyroid","volume":"19","author":"Raggio","year":"2019","journal-title":"Ochsner J."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Vrinceanu, D., Dumitru, M., Marinescu, A., Serboiu, C., Musat, G., Radulescu, M., Popa-Cherecheanu, M., Ciornei, C., and Manole, F. (2024). Management of Giant Thyroid Tumors in Patients with Multiple Comorbidities in a Tertiary Head and Neck Surgery Center. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102204"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"bvab059","DOI":"10.1210\/jendso\/bvab059","article-title":"Thyroid Cancer and Telemedicine During the COVID-19 Pandemic","volume":"5","author":"Chablani","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1093\/bjs\/znab012","article-title":"Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer in Italy: Nationwide Retrospective Study","volume":"108","author":"Medas","year":"2021","journal-title":"Br. J. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40618-020-01407-1","article-title":"Thyroid Surgery During Coronavirus-19 Pandemic Phases I, II and III: Lessons Learned in China, South Korea, Iran and Italy","volume":"44","author":"Zhang","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"R407","DOI":"10.1530\/ERC-20-0279","article-title":"Thyroid Cancer in the Age of COVID-19","volume":"27","author":"Tsang","year":"2020","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"bvab076","DOI":"10.1210\/jendso\/bvab076","article-title":"COVID-19 and Thyroid Diseases: A Bidirectional Impact","volume":"5","author":"Duntas","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3390\/curroncol28030173","article-title":"Psychosocial Distress in Adult Patients Awaiting Cancer Surgery during the COVID-19 Pandemic","volume":"28","author":"Forner","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.3390\/curroncol31100466","article-title":"No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery","volume":"31","author":"Nocini","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_84","first-page":"e55506","article-title":"Disparities in the Place of Death for Patients With Malignant Neoplasms of the Thyroid Gland","volume":"16","author":"Anupiya","year":"2024","journal-title":"Cureus"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eprac.2020.12.013","article-title":"COVID-19 Outcomes of Patients with Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study","volume":"27","author":"Mosaferi","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_86","first-page":"e72274","article-title":"High Procalcitonin Does Not Always Indicate a Bacterial Infection","volume":"16","author":"Shahzad","year":"2024","journal-title":"Cureus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.12998\/wjcc.v10.i20.7171","article-title":"Incidental diagnosis of medullary thyroid carcinoma due to persistently elevated procalcitonin in a patient with COVID-19 pneumonia: A case report","volume":"10","author":"Saha","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.aace.2021.05.001","article-title":"Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma","volume":"7","author":"Gianotti","year":"2021","journal-title":"AACE Clin. Case Rep."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sira, L., Balogh, Z., Vit\u00e1lis, E., Kov\u00e1cs, D., Gy\u0151ry, F., Moln\u00e1r, C., Bodor, M., and Nagy, E.V. (2021). Case Report: Medullary Thyroid Cancer Workup Initiated by Unexpectedly High Procalcitonin Level-Endocrine Training Saves Life in the COVID-19 Unit. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.727320"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ashrafi, S., Hatami, H., Bidhendi-Yarandi, R., and Panahi, M.H. (2024). The Prevalence of Thyroid Disorders in COVID-19 Patients: A Systematic Review and Meta-Analysis. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-023-01534-9"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/clinem\/dgaa813","article-title":"Thyroid Dysfunction in Relation to Immune Profile, Disease Status and Outcome in 191 Patients with COVID-19","volume":"106","author":"Lui","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer Patients in SARS-Cov-2 Infection: A Nationwide Analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/cen.14453","article-title":"COVID-19 related thyroiditis: A novel disease entity?","volume":"95","author":"Dworakowska","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: Post-Acute Sequelae of COVID-19 with A Cardiovascular Focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Abramczyk, U., Nowaczy\u0144ski, M., S\u0142omczy\u0144ski, A., Wojnicz, P., Zatyka, P., and Kuzan, A. (2022). Consequences of COVID-19 for the Pancreas. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020864"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.advms.2024.01.003","article-title":"Effect of Advanced Glycation End-Products in A Wide Range of Medical Problems Including COVID-19","volume":"69","author":"Kuzan","year":"2024","journal-title":"Adv. Med. Sci."},{"key":"ref_97","first-page":"100284","article-title":"COVID-19 and Chronic Fatigue Syndrome: An Endocrine Perspective","volume":"27","author":"Bansal","year":"2022","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and Predictors of Long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"102235","DOI":"10.1016\/j.dsx.2021.102235","article-title":"Post COVID-19 Syndrome (\u201cLong COVID\u201d) and Diabetes: Challenges in Diagnosis and Management","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_100","first-page":"143","article-title":"Lack of Evidence of the Correlation Between Plasma Asymmetrical Dimethylarginine Correlation and IMT in Type 2 Diabetic Patients with Chronic Vascular Complication","volume":"68","author":"Dumas","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"601","DOI":"10.17219\/acem\/62663","article-title":"Physical Activity\u2014Related Changes in ADMA and Vwf Levels in Patients with Type 2 Diabetes: A Preliminary Study","volume":"26","author":"Dumas","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2021.05.004","article-title":"Epidemiology and Organ Specific Sequelae of Post-Acute COVID19: A Narrative Review","volume":"83","author":"Korompoki","year":"2021","journal-title":"J. Infect."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Qu, N., Hui, Z., Shen, Z., Kan, C., Hou, N., Sun, X., and Han, F. (2022). Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development. Front. Endocrinol., 3.","DOI":"10.3389\/fendo.2022.873027"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-Cov-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Bronowicka-Szyde\u0142ko, A., Lewandowski, \u0141., Lubieniecki, P., Adamiec-Mroczek, J., Doroszko, A., Trocha, M., Kujawa, K., Matera-Witkiewicz, A., Rabczy\u0144ski, M., and Ku\u017anik, E. (2024). Pre-Hospital Oxygen Therapy and Saturation Variability in COVID-19 Patients with and without Glucose Metabolism Disorders: Part of the COLOS Study. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-70240-w"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Lewandowski, \u0141., Bronowicka-Szyde\u0142ko, A., Rabczy\u0144ski, M., Bednarska-Chabowska, D., Adamiec-Mroczek, J., Doroszko, A., Trocha, M., Kujawa, K., Matera-Witkiewicz, A., and Ku\u017anik, E. (2024). Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030605"},{"key":"ref_107","first-page":"e43473","article-title":"Impact of the COVID-19 Pandemic on the Management of Gallbladder, Biliary Tract, and Pancreatic Diseases","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Paleczny, B., Seredy\u0144ski, R., Wyciszkiewicz, M., Nowicka-Czudak, A., \u0141opusiewicz, W., Adamiec, D., Wiecha, S., Mroczek, D., Chmura, P., and Konefa\u0142, M. (2021). Low Ventilatory Responsiveness To Transient Hypoxia Or Breath-Holding Predicts Fast Marathon Performance in Healthy Middle-Aged and Older Men. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-89766-4"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1113\/EP089113","article-title":"Acute Effects of Increased Gut Microbial Fermentation on the Hypoxic Ventilatory Response in Humans","volume":"106","author":"Ponikowska","year":"2021","journal-title":"Exp. Physiol."},{"key":"ref_110","first-page":"e33319","article-title":"Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"key":"ref_111","first-page":"138","article-title":"Differentiating Among Type 1, Type 2 Diabetes, and MODY: Raising Awareness About the Clinical Implementation of Genetic Testing in Latin America","volume":"7","author":"Segura","year":"2020","journal-title":"AACE Clin. Case Rep."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Chudek, J., Kolonko, A., Ziaja, J., Francuz, T., Kami\u0144ska, D., Owczarek, A.J., Kuczera, P., Kujawa-Szewieczek, A., Kusztal, M., and Kowalik, A.P. (2021). Beneficial Effect of Successful Simultaneous Pancreas-Kidney Transplantation on Plasma Profile of Metalloproteinases in Type 1 Diabetes Mellitus Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10173800"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/archdischild-2020-321220","article-title":"New-Onset Type 1 Diabetes in Finnish Children During the COVID-19 Pandemic","volume":"107","author":"Salmi","year":"2022","journal-title":"Arch. Dis. Child."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e28833","DOI":"10.1002\/jmv.28833","article-title":"New-Onset Type 1 Diabetes in Children and Adolescents As Postacute Sequelae of SARS-Cov-2 Infection: A Systematic Review and Meta-Analysis of Cohort Studies","volume":"95","author":"Rahmati","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Rabczy\u0144ski, M., Chwa\u0142ek, S., Adamiec-Mroczek, J., Lewandowski, \u0141., Trocha, M., Nowak, B., Misiuk-Hoj\u0142o, M., Bednarska-Chabowska, D., Ku\u017anik, E., and Lubieniecki, P. (2024). Neutrophil Elastase, Neuron-Specific Enolase, and S100B Protein as Potential Markers of Long-Term Complications Caused by COVID-19 in Patients with Type 2 Diabetes Mellitus (T2DM) and Advanced Stage of Diabetic Nephropathy (NfT2DM)-Observational Studies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111791"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"947594","DOI":"10.3389\/fendo.2022.947594","article-title":"Association of Thyroid Dysfunction and COVID-19: A Systematic Review And Meta-Analysis","volume":"13","author":"Darvishi","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/2211-5463.12984","article-title":"An Investigation into the Molecular Basis of Cancer Comorbidities in Coronavirus Infection","volume":"10","author":"Facchiano","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3892\/etm.2021.10188","article-title":"COVID-19-Related Thyroid Conditions (Review)","volume":"22","author":"Carsote","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_119","first-page":"7610","article-title":"The Role of T2E Mediated CBF-1\/RBP-J\u03ba Signaling in Metastatic Thyroid Cancer","volume":"13","author":"Hu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Kuzan, A., Kr\u00f3lewicz, E., Nowakowska, K., Stach, K., Kaliszewski, K., Domos\u0142awski, P., Kotyra, \u0141., Gamian, A., and Kustrzeba-W\u00f3jcicka, I. (2021). Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology\u2014A Pilot Study. Biomolecules, 11.","DOI":"10.3390\/biom11040557"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Rossini, A., Cassibba, S., Perticone, F., Benatti, S.V., Venturelli, S., Carioli, G., Ghirardi, A., Rizzi, M., Barbui, T., and Trevisan, R. (2023). Increased Prevalence of Autoimmune Thyroid Disease After COVID-19: A Single-Center, Prospective Study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1126683"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.21037\/atm-20-4281","article-title":"Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study","volume":"8","author":"Han","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.2147\/JIR.S332705","article-title":"SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases","volume":"14","author":"Murugan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.15605\/jafes.035.02.01","article-title":"COVID-19 and Thyroid Diseases: How the Pandemic Situation Affects Thyroid Disease Patients","volume":"35","author":"Pramono","year":"2020","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40336-021-00419-y","article-title":"Prevalence of Thyroid Dysfunction in Patients with COVID-19: A Systematic Review","volume":"9","author":"Giovanella","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1530\/EC-21-0301","article-title":"Thyroid Function in COVID-19 and the Association with Cytokine Levels and Mortality","volume":"10","author":"Clausen","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.2147\/DDDT.S475005","article-title":"Cytokine Storm-induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches","volume":"18","author":"Attiq","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"108172","DOI":"10.1016\/j.intimp.2021.108172","article-title":"Cytokine Storm in the Pathophysiology of COVID-19: Possible Functional Disturbances of miRNAs","volume":"101","author":"Aslani","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1507\/endocrj.EJ20-0443","article-title":"Thyroid Complications of SARS and Coronavirus Disease 2019 (COVID-19)","volume":"68","author":"Speer","year":"2021","journal-title":"Endocr. J."},{"key":"ref_131","first-page":"100094","article-title":"Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves\u2019 disease, and subacute thyroiditis","volume":"22","author":"Feghali","year":"2021","journal-title":"J. Clin. Transl. Endocrinol. Case Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/JCMA.0000000000000319","article-title":"Gastrointestinal and liver manifestations in patients with COVID-19","volume":"83","author":"Lee","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"Pkaa120","DOI":"10.1093\/jncics\/pkaa120","article-title":"Rates of COVID-19-Related Outcomes in Cancer Compared with Noncancer Patients","volume":"5","author":"Sun","year":"2021","journal-title":"JNCI Cancer Spectr."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/07435800.2020.1767127","article-title":"Coronaviruses and Integrin \u03b1v\u03b23: Does Thyroid Hormone Modify the Relationship?","volume":"45","author":"Davis","year":"2020","journal-title":"Endocr. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12020-021-02650-z","article-title":"Thyroid cancer and COVID-19: Experience at one single thyroid disease referral center","volume":"72","author":"Prete","year":"2021","journal-title":"Endocrine"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-020-02439-6","article-title":"Thyroid Cancer in the Era of COVID-19","volume":"70","author":"Smulever","year":"2020","journal-title":"Endocrine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3329\/jdmc.v29i2.51194","article-title":"COVID-19 Pandemic and Thyroid Cancer Treatment in Perspective of Bangladesh","volume":"29","author":"Rifat","year":"2020","journal-title":"J. Dhaka Med. Coll."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Zhang, C., Jin, H., Wen, Y.F., and Yin, G. (2021). Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.729559"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40495-020-00225-6","article-title":"Colchicine in COVID-19: An Old Drug, New Use","volume":"6","author":"Schlesinger","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.18632\/oncotarget.7890","article-title":"High-Throughput Drug Library Screening Identifies Colchicine as A Thyroid Cancer Inhibitor","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Puhl, A.C., Gomes, G.F., Damasceno, S., Fritch, E.J., Levi, J.A., Johnson, N.J., Scholle, F., Premkumar, L., Hurst, B.L., and LeeMontiel, F. (2021). Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice. bioRxiv Prepr.","DOI":"10.1101\/2021.12.16.472155"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in Progressive Medullary Thyroid Cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_143","first-page":"572","article-title":"Interdisciplinary Recommendations for the Treatment of Advanced Metastatic Renal Cell Carcinoma","volume":"51","author":"Miller","year":"2020","journal-title":"Aktuelle Urol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2008.16.3279","article-title":"Phase II Trial of Sorafenib in Advanced Thyroid Cancer","volume":"26","author":"Troxel","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2008.18.2717","article-title":"Phase II Trial of Sorafenib in Metastatic Thyroid Cancer","volume":"27","author":"Kloos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1200\/JCO.2009.25.0068","article-title":"Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer","volume":"28","author":"Lam","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1158\/1535-7163.MCT-06-0595","article-title":"Sorafenib Inhibits the Angiogenesis and Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice","volume":"6","author":"Kim","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1089\/thy.2016.0621","article-title":"Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma","volume":"27","author":"Ito","year":"2017","journal-title":"Thyroid"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Taguchi, Y.-H., and Turki, T. (2020). A New Advanced in Silico Drug Discovery Method for Novel Coronavirus (SARS-CoV-2) with Tensor Decomposition-Based Unsupervised Feature Extraction. PLoS ONE, 15.","DOI":"10.20944\/preprints202004.0524.v1"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/CAD.0000000000001097","article-title":"Lenvatinib Treatment for Thyroid Cancer in COVID Era: Safety in A Patient with Lung Metastases and SARS-Cov-2 Infection","volume":"32","author":"Locantore","year":"2021","journal-title":"Anticancer Drugs"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","article-title":"Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 Via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 kinase","volume":"14","author":"Matsui","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40262-018-0703-0","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib","volume":"58","author":"Puszkiel","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"173594","DOI":"10.1016\/j.ejphar.2020.173594","article-title":"Integrative Transcriptomics Analysis of Lung Epithelial Cells and Identification of Repurposable Drug Candidates for COVID-19","volume":"887","author":"Islam","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/acsinfecdis.0c00486","article-title":"High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2","volume":"7","author":"Wan","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/1386207323999200730205447","article-title":"Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening","volume":"24","author":"Chtita","year":"2021","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-020-01343-7","article-title":"Selpercatinib: First Approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1002\/hed.26527","article-title":"Neoadjuvant Selpercatinib for Advanced Medullary Thyroid Cancer","volume":"43","author":"Jozaghi","year":"2021","journal-title":"Head Neck"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"114765","DOI":"10.1016\/j.molliq.2020.114765","article-title":"Structural Investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib","volume":"325","author":"Pooventhiran","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_160","first-page":"PO.17.00105","article-title":"Response to Entrectinib in Differentiated Thyroid Cancer with a ROS1 Fusion","volume":"1","author":"Liu","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijbiomac.2021.11.124","article-title":"Identifying Potential Novel Insights for COVID-19 Pathogenesis and Therapeutics Using An Integrated Bioinformatics Analysis of Host Transcriptome","volume":"194","author":"Mahmoud","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Peralta-Garcia, A., Torrens-Fontanals, M., Stepniewski, T.M., Grau-Exp\u00f3sito, J., Perea, D., Ayinampudi, V., Waldhoer, M., Zimmermann, M., Buz\u00f3n, M.J., and Genesc\u00e0, M. (2021). Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.09.07.459123"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17512433.2019.1661775","article-title":"Larotrectinib, A Highly Selective Tropomyosin Receptor Kinase (TRK) Inhibitor for the Treatment of TRK Fusion Cancer","volume":"10","author":"Federman","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMc2023094","article-title":"Larotrectinib-Enhanced Radioactive Iodine Uptake in Advanced Thyroid Cancer","volume":"383","author":"Groussin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/07391102.2020.1813200","article-title":"Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro","volume":"40","author":"Abhithaj","year":"2022","journal-title":"Biomol. Struct. Dyn."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/clpt.2013.197","article-title":"Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies","volume":"95","author":"Jang","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"105771","DOI":"10.1016\/j.ejps.2021.105771","article-title":"In Silico Identification of Available Drugs Targeting Cell Surface Bip to Disrupt SARS-Cov-2 Binding and Replication: Drug Repurposing Approach","volume":"160","author":"Zhang","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jjco\/hyy053","article-title":"Drug Review: Pazopanib","volume":"48","author":"Miyamoto","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(10)70203-5","article-title":"Endocrine Malignancies Disease Oriented Group; Mayo Clinic Cancer Center; Mayo Phase 2 Consortium. Efficacy of Pazopanib in Progressive, Radioiodine-Refractory, Metastatic Differentiated Thyroid Cancers: Results of A Phase 2 Consortium Study","volume":"11","author":"Bible","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2013-3713","article-title":"Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H","volume":"99","author":"Bible","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1158\/1078-0432.CCR-10-0994","article-title":"Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation","volume":"16","author":"Carr","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3892\/ol.2020.11685","article-title":"Anlotinib as a molecular targeted therapy for tumors","volume":"20","author":"Gao","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-17-0243","article-title":"Axitinib Treatment in Advanced RAI-Resistant Differentiated Thyroid Cancer (DTC) and Refractory Medullary Thyroid Cancer (MTC)","volume":"177","author":"Capdevila","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1200\/JCO.2007.15.9566","article-title":"Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results from a Phase II Study","volume":"26","author":"Cohen","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ejca.2015.05.020","article-title":"An Open Label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer","volume":"51","author":"Lim","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: Combining Antiviral and Anti-inflammatory Treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Girgis, A.S., Panda, S.S., Srour, A.M., Abdelnaser, A., Nasr, S., Moatasim, Y., Kutkat, O., El Taweel, A., Kandeil, A., and Mostafa, A. (2021). 3-Alkenyl-2-oxindoles: Synthesis, Antiproliferative and Antiviral Properties Against SARS-CoV-2. Bioorg. Chem., 114.","DOI":"10.1016\/j.bioorg.2021.105131"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-319-91442-8_8","article-title":"Everolimus","volume":"211","author":"Hasskarl","year":"2018","journal-title":"Recent Results Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"104609","DOI":"10.1016\/j.phrs.2019.104609","article-title":"Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors: A 2020 Update","volume":"152","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1093\/annonc\/mdt379","article-title":"A Multicenter, Phase II Trial of Everolimus in Locally Advanced or Metastatic Thyroid Cancer of All Histologic Subtypes","volume":"24","author":"Lim","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/1078-0432.CCR-17-2297","article-title":"Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study","volume":"24","author":"Hanna","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An Oscillatory Switch in Mtor Kinase Activity Sets Regulatory T Cell Responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Terrazzano, G., Rubino, V., Palatucci, A.T., Giovazzino, A., Carriero, F., and Ruggiero, G. (2020). An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00856"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (Keytruda)","volume":"12","author":"Kwok","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Mehnert, J.M., Varga, A., Brose, M.S., Aggarwal, R.R., Lin, C.C., Prawira, A., de Braud, F., Tamura, K., Doi, T., and Piha-Paul, S.A. (2019). Safety and Antitumor Activity of the Anti-PD-1 Antibody Pembrolizumab in Patients with Advanced, PD-L1-Positive Papillary or Follicular Thyroid Cancer. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5380-3"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e000530","DOI":"10.1136\/jitc-2020-000530","article-title":"A First-in-Human Phase 1 Dose Escalation Study of Spartalizumab (PDR001), An Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors","volume":"8","author":"Naing","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.19.02727","article-title":"PD-1 Blockade in Anaplastic Thyroid Carcinoma","volume":"38","author":"Capdevila","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e146701","DOI":"10.1172\/jci.insight.146701","article-title":"PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response","volume":"6","author":"Loretelli","year":"2021","journal-title":"JCI Insight"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/12\/2829\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:03Z","timestamp":1760115243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/12\/2829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":188,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biomedicines12122829"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12122829","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}